V

Viriom

3 employees

Viriom is a clinical and commercial stage biotech developing drugs for treatment, prevention and cure of HIV and other infections.

Basic info

Industry

pharmaceuticals

Sectors

Biotechnology
Health Care
Pharmaceutical

Date founded

2009

Funding rounds raised

Total raised

$3M

from 6 investors over 6 rounds

V

Viriom raised $2.6M on June 6, 2017

Investors: Torrey Pines Investment

V

Viriom raised $2.4M on May 11, 2016

Investors: Torrey Pines Investment, Skolkovo Foundation and ChemRar High Tech Center

V

Viriom raised $3M on September 1, 2015

Investors: Torrey Pines Investment

V

Viriom raised undisclosed on July 27, 2009

Investors: Torrey Pines Investment

FAQ